The Choice for Saving Lives

James B. Benton, MD

james-benton-head

Dr. James Benton has been a certified radiation oncologist since 1997. He has practiced at Radiotherapy Centers of Georgia’s main center in Decatur since 1998, primarily treating prostate cancer patients. Before joining RCOG, Dr. Benton served as Chief Resident of Radiation Oncology at Emory University Hospital in Atlanta.

As a young boy living in Savannah, Dr. Benton thought often about growing up to be a physician. He earned his medical degree at Morehouse School of Medicine, graduating first in his class.  From there, he went to the Medical College of Virginia to serve his internal medicine residency. Dr. Benton completed his radiation oncology residency at Emory University in 1996, eventually becoming chief resident before coming to RCOG.

“Many facilities offer treatments similar to what we do. Over the years, we have treated a lot of prostate cancers, but it’s the quality of the work we do that makes us different,” Dr. Benton says.

Dr. Benton’s love of math, physics, and science led him to radiation oncology, a specialty he admires for the depth of its technical detail and the breadth of its clinical application.

dr.benton

Medical School:
Morehouse School of Medicine Medical College of Georgia, 1983–1987

Residency:
Radiation Oncology Residency, Emory University, 1993–1996
Chief Resident, Radiation Oncology, Emory University, 1995–1996
Internal Medicine Residency, Medical College of Virginia, 1987–1990
Nominated Chief Resident, Internal Medicine, 1989

Board Certification:
Board Certified in Radiation Oncology, 1997
Board Certified in Internal Medicine ACLS Instructor

Military Service:
U.S. Navy, 1975–1979

Other:
Principle Investigator for the Radiation Therapy Oncology Group, an NCI-supported Intergroup Organization, 1997–1998

Published articles by Dr. Benton

Cigarette Smoking Does Not Affect Treatment Results of Simultaneous Irradiation For Prostate Cancer
J.B. Benton, F.A. Critz, A.K. Levinson, F.J. Schnell, P.D. Shrake. ASCO Proceedings, 22:444, 2003.

Patient Age Related To Prostate Specific Antigen Bound By Recursive Partitioning Analysis After Brachytherapy For Prostate Cancer
F.A. Critz, J.B. Benton, F.J. Schnell, P.D. Shrake, A. Ciampi, A. Couturier. ASCO Proceedings, 22:438, 2003.

Pretreatment Erectile Function Of Men Who Underwent Brachytherapy For Prostate Cancer
F.J. Schnell, F.A. Critz, J.B. Benton, P.D. Shrake. ASCO Proceedings, 22:444, 2003.

Probability of Achieving PSA Nadir 0.5 Ng/ml After Radiotherapy of Prostate Cancer
V.Griffin, F. Critz, K. Levinson, J. Benton. ASCO Proceedings, 18:339a, 1999.

Prostate Cancer in African-American Men Treated by Simultaneous Radiotherapy
F.Critz, K. Levinson, V. Griffin, J. Benton. ASCO Proceedings 18, 1999.

Prostate Specific Antigen Nadir After Brachytherapy for Prostate Cancer Correlates With Prognosis of Men Who Recur
Frank A. Critz, A. Keith Levinson, James B. Benton, Frederick J. Schnell, and Philip D. Shrake. J Urol 169 (supplement):179, 2003.

A Standard Definition of Disease Freedom is Needed for Prostate Cancer
F. Critz, J. Benton, F. Schnell, P. Shrake. American Brachytherapy Society Meeting. ABS Proceedings, 1:57, 2001.

Acute and Late Morbidity Following Simultaneous Irradiation for Prostate Cancer
F.A. Critz, K. Levinson, F. Schnell, J. Benton, P. Shrake. ASCO Proceedings, 20:189a, 2001.

Disease Free Survival Rates Following Irradiation of Prostate Cancer According to Age
J.B. Benton, F.A. Critz, F.J. Schnell, P.D. Shrake. ASCO Proceedings, 21:167B, 2002.

Sexual Function Following Simultaneous Irradiation for Prostate Cancer
F.A Critz, J.B. Benton, F.J. Schnell, P.D. Shrake. ASCO Proceedings, 21:188a, 2002.

Ten-Year Disease Free Survival Rate Calculated With PSA Cutpoint 0.2 ng/ml In Men After Brachytherapy For Prostate Cancer
F.A. Critz, A. Keith Levinson, J. B. Benton, F.J. Schnell, P.D. Shrake. J Urol 169 (supplement):181, 2003.

Treatment of Gleason Score 7 Prostate Cancer with I-125 Implant Followed by External Beam Radiotherapy
J. Benton, F.A. Critz, K. Levinson, V. Griffin. ASCO Proceedings, 18:317a, 1999.

Young Men with Prostate Cancer Treated by Simultaneous Radiotherapy
A. A. Sheikh, F.A. Critz, A.K. Levinson, J.B. Benton, F. Schnell, P. Shrake, L.S. Maxa. ASCO Proceedings, 19:227a, 2000.

Obstructive Uropathy Following Simultaneous Irradiation For Prostate Cancer Measured By A Longitudinal Study of The American Urological Association Symptom Index For Benign Prostate Hyperplasia
F.A. Critz, A. Keith Levinson, James B. Benton, F.J. Schnell, Philip D. Shrake. ABS Proceedings, 2:67, 2003.

Postirradiation Prostatitis: A Previously Unrecognized Syndrome Following Brachytherapy For Prostate Cancer
F.A. Critz, A.K. Levinson, J.B. Benton, F.J. Schnell, P.D. Shrake. ABS Proceedings, 2:66, 2003.

See all of RC Cancer’s published articles..